Clinical Application of Mass Spectrometry-Based Proteomics in Lung Cancer Early Diagnosis

Research output: Contribution to journalReview articlepeer-review


The current knowledge on proteomic biomarker analysis for the early diagnosis of lung cancer is summarized, underlining the diversity among the results and the current interest in translating research results into clinical practice. A MEDLINE/PubMed literature search to retrieve all the papers published in the last 10 years is performed. Proteomics studies on lung cancer have gathered evidence on the potential role of biomarkers in early diagnosis. Although promising, none of them have proved to be sufficiently reliable to achieve validation. Future research should evolve toward a multipanel analysis of proteins, considering the possibility that individual biomarkers might not be specific enough to diagnose lung cancer, but could be related to oncological conditions.

Original languageEnglish
Article number1900138
JournalProteomics - Clinical Applications
Issue number5
Publication statusPublished - Sep 1 2020


  • lung cancer
  • proteomics
  • translational medicine

ASJC Scopus subject areas

  • Clinical Biochemistry


Dive into the research topics of 'Clinical Application of Mass Spectrometry-Based Proteomics in Lung Cancer Early Diagnosis'. Together they form a unique fingerprint.

Cite this